Corlux

Catalysts On Tap For Corcept Therapeutics
Seeking Alpha
Tue, 02/7/12 - 10:37 am
Corcept Therapeutics
Korlym
Cushing's syndrome
Corlux
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Corcept Therapeutics says FDA will make decision on Cushing's Syndrome drug Corlux by Feb. 17
Yahoo/AP
Thu, 06/30/11 - 09:31 am
Corcept Therapeutics
FDA
Cushing's disease
Corlux
Corcept Therapeutics details Corlux study results
Yahoo/AP
Mon, 06/6/11 - 09:33 pm
Corcept Therapeutics
Corlux
Cushing's syndrome
Corcept Therapeutics Announces Detailed Findings From Phase 3 Study Which Show CORLUX Significantly Improves Clinical and Metabolic Manifestations of Cushing's Syndrome
Yahoo/MarketWire
Sun, 06/5/11 - 10:01 am
Corcept Therapeutics
Corlux
Cushing's syndrome
Corcept Therapeutics Announces NDA Submitted to the FDA for the Use of CORLUX in Cushing's Syndrome
Yahoo/MarketWire
Sat, 04/16/11 - 01:10 pm
Corcept Therapeutics
Corlux
Cushing's disease
Corcept May Have Hit Pay Dirt
Motley Fool
Mon, 12/27/10 - 08:33 am
Corcept Therapeutics
Corlux
Cushing's disease
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Mon, 09/27/10 - 05:40 pm
Ariad Pharmaceuticals
Corcept Therapeutics
ridaforolimus
Merck
Cushing's disease
Corlux
Novartis